IRIS
RUBAGOTTI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.065
AS - Asia 1.739
NA - Nord America 582
SA - Sud America 133
AF - Africa 31
OC - Oceania 1
Totale 21.551
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 18.749
SG - Singapore 826
US - Stati Uniti d'America 540
CN - Cina 502
VN - Vietnam 236
FR - Francia 156
BR - Brasile 85
HK - Hong Kong 61
FI - Finlandia 43
DE - Germania 33
JP - Giappone 31
AR - Argentina 28
CH - Svizzera 22
MX - Messico 20
GB - Regno Unito 17
BD - Bangladesh 15
CA - Canada 12
IQ - Iraq 12
NL - Olanda 9
MA - Marocco 8
RU - Federazione Russa 8
ES - Italia 7
ID - Indonesia 7
PH - Filippine 7
CO - Colombia 6
VE - Venezuela 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
DZ - Algeria 4
IN - India 4
KE - Kenya 4
PK - Pakistan 4
PL - Polonia 4
SA - Arabia Saudita 4
IE - Irlanda 3
JO - Giordania 3
SE - Svezia 3
TH - Thailandia 3
UY - Uruguay 3
DO - Repubblica Dominicana 2
EC - Ecuador 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KW - Kuwait 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
RE - Reunion 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TR - Turchia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
GA - Gabon 1
GN - Guinea 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MM - Myanmar 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TW - Taiwan 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 21.551
Salva come PNG Salva come JPEG
Città #
Genova 12.100
Genoa 3.766
Rapallo 1.634
Vado Ligure 1.189
Singapore 401
San Jose 262
Lauterbourg 156
Ho Chi Minh City 66
Hanoi 62
Hong Kong 59
Ashburn 58
Beijing 46
Helsinki 43
Bordighera 30
Tokyo 27
Frankfurt am Main 24
Santa Clara 24
New York 23
Zurich 22
Council Bluffs 14
Tianjin 13
Mexico City 12
Haiphong 11
Biên Hòa 8
Amsterdam 7
Chicago 7
Orem 7
Atlanta 5
City of London 5
Jakarta 5
Los Angeles 5
Shanghai 5
São Paulo 5
Can Tho 4
Curitiba 4
Des Moines 4
Guangzhou 4
Hải Dương 4
Kunming 4
Naples 4
Quảng Ngãi 4
Rio de Janeiro 4
Vĩnh Long 4
Amman 3
Baghdad 3
Da Nang 3
Dallas 3
Dhaka 3
Dublin 3
London 3
Marrakesh 3
Montevideo 3
Montreal 3
Porto Alegre 3
Shenzhen 3
Stockholm 3
Toronto 3
Warsaw 3
Baku 2
Bangkok 2
Belo Horizonte 2
Brasília 2
Cape Town 2
Caracas 2
Casablanca 2
Dammam 2
Dosquebradas 2
Erbil 2
Florence 2
Friedrichshafen 2
Guatemala City 2
Ha Long 2
Haikou 2
Jaboatão dos Guararapes 2
Kuwait City 2
Madrid 2
Manchester 2
Manila 2
Maracaibo 2
Mogi Guaçu 2
Mosul 2
Münster 2
Nairobi 2
Nuremberg 2
Poplar 2
Querétaro City 2
Quận Bình Thạnh 2
Quận Ninh Kiều 2
Rome 2
Salvador 2
Shijiazhuang 2
Suzhou 2
Teramo 2
Thái Bình 2
Thái Nguyên 2
Villa José León Suárez 2
Volta Redonda 2
Vĩnh Tường 2
Abidjan 1
Agadir 1
Totale 20.268
Salva come PNG Salva come JPEG
Nome #
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years 283
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome 244
Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials 205
Adjuvant immunochemotherapy in colorectal cancer Dukes C. 202
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial. 197
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group. 193
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes 182
"Autologous Bone Marrow Transplantation for Adult Advanced Stage Lymphoblastic Lymphoma in First CR. A Study of the NHLCSG". 181
Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines. 179
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study 179
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials 178
Prognostic value of preoperative serum levels of periostin (PN) in early breast cancer (BCa) 178
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer 177
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. 174
Differential expression of nuclear lamins in normal and cancerous prostate tissues 174
Targeting androgen-independent pathways: new chances for patients with prostate cancer? 165
Combination of sorafenib and weekly gemcitabine in patients (pts) with metastatic renal cell Cancer (MRCC): A phase II study, preliminary results 164
Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery 164
Paclitaxel plus organoplatins: still the gold standard in advanced ovarian cancer? 161
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials 161
Intracystic epidermal growth factor level is predictive of breast-cancer risk in women with gross cystic disease of the breast 160
Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. 160
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials 159
Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death 158
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: updated results of a multicentric trial. 158
68P * Prognostic value of periostin (PN) expression in early breast cancer (BCa): Long-term mortality outcomes 158
Prognostic value of nuclear matrix protein expression in localized prostate cancer. 158
Phase II study with high-dose N5-10-methyltetrahydrofolate and 5-fluorouracil in advanced colorectal cancer. 157
48: Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. 156
84: [Antibiotic preparation in operations on the large intestine. Experimental study] GF, Rollandi GA. 155
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. 154
A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients. 153
Periostin: A Novel Prognostic and Therapeutic Target For Genitourinary Cancer? 153
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer 153
Switching to aromatase inhibitors in early breast cancer. 149
Cardiovascular disease (CVD) markers in patients(pts) with prostate cancer(PCa) treated with GN-RH agonists(AG) or antagonist(AN): a prospective cohort study 149
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. 148
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients 147
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study 146
Long-acting (depot) D-TRP-6 LH-RH (Decapeptyl) in prostate cancer. An Italian multicentric trial. 145
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients. 145
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial. 144
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Long term results of the Italian Tamoxifen Anastrozole trial. 144
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer 143
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer 143
Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk. 141
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen. Results of the GROCTA trial. 141
Combined DNA flow cytometry and sorting with k-ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer. 140
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial. 140
Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer 139
VACOP-B Versus VACOP-B Plus Autologous Bone Marrow Transplantation for Advanced Diffuse Non-Hodgkin's Lymphoma: Results of a Prospective Randomized Trial by the Non-Hodgkin's Lymphoma Cooperative Study Group 139
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study 139
Chemoradiotherapy in locally advanced bladder cancer: neoadjuvant and definitive treatment 138
Chemotherapy (CT) versus tamoxifen (T) versus chemoterapy plus tamoxifen (CTT) in patients with node-positive (N+), estrogen receptor-positive (ER+) breast cancer (bca): Very late results of an Italian multicentric trial 138
Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study. 138
An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients 138
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. 137
Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. 137
The impact of received dose intensity on the outcome of advanced ovarian cancer. 136
Fattibilità della Terapia Adiuvante Intraperitoneale e Sistemica in Pazienti Operati Radicalmente per Carcinoma del Colon. 135
O-4 Ovarian suppression (OS) and tamoxifen (TAM) as an alternative to chemotherapy in early breast cancer. Long-term results of the GROCTA02 trial 135
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes 135
Carboplatin, Doxorubicin, and Cyclophosphamide Versus Cisplatin, Doxorubicin, and Cyclophosphamide: a Randomized Trial in Stage III-IV Epithelial Ovarian Carcinoma" 134
Adjuvant chemotherapy (AC) with cisplatin + gemcitabine (CG) versus chemotherapy (CT) at relapse (CR) in patients (pts) with muscle-invasive bladder cancer (MIBC) submitted to radical cystectomy (RC). An Italian multicenter randomised phase III trial 134
A. Lettera a: Journal of Clinical Oncology, 1987; 5, N. 4. 133
Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer. 133
A Randomized Study in Metastatic Breast Cancer (MBC) Comparing Conventional Chemotherapy Vs Chemotherapy with Estrogenic Recruitment." 133
Randomized cooperative study of perioperative chemotherapy in breast cancer. 133
Safety of antiandrogen therapy for treating prostate cancer. 133
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, Italy. 132
The prognostic value of stromal and epithelial periostin expression in human breast cancer: Correlation with clinical pathological features and mortality outcome 132
Analysis of time to response to chemotherapy in 316 metastatic breast cancer patients. 129
Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer. 129
Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial 129
Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study 129
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis. 129
D-TRP-6 LH-RH treatment of prostatic cancer. 127
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lung. 127
Gynaecomastia: the anastrozole paradox 126
Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group 125
Etoposide v etoposide and cisplatin in the treatment of advanced non-small cell lung cancer: a FONICAP randomized study. 124
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial 124
Insights from a long-term follow-up evaluation of early breast cancer (BC) outcomes by tumor subtype (TS) 124
Randomized trial of chemoimmunotherapy in advanced non-oat-cell lung cancer. 123
High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy. 123
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest. 122
Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. 121
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. 121
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO). 120
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group. 120
Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast. 120
Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients 120
Long-term results with a long-acting formulation of D-TRP-6 LH-RH in patients with prostate cancer: an Italian prostatic cancer project (P.O.N.CA.P.) study. 119
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. 119
Stimulation of human breast cancer in vivo. Experimental findings and clinical results. 119
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look. 118
Prednisone plus Gefitinib (pG) versus prednisone plus placebo (ppl) in the treatment of hormone-refractory prostate cancer (HRPC). A randomized phase II trial. 118
High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow. 1999 Apr;33(3-4):321-30 117
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study 117
Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma. 117
Totale 14.635
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.690
article - articoli 63.947
book - libri 0
conference - conferenze 278
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.465
Totale 137.380
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021291 0 0 0 0 0 0 0 0 0 125 78 88
2021/20222.048 47 135 131 261 75 153 74 548 112 188 53 271
2022/20231.941 194 105 23 202 364 399 1 142 340 9 134 28
2023/2024898 48 143 16 99 90 154 54 64 35 29 53 113
2024/20252.741 53 235 89 194 422 290 263 427 103 110 228 327
2025/20263.873 484 114 226 313 600 509 784 221 243 379 0 0
Totale 21.816